12:00 AM
 | 
Feb 04, 2013
 |  BC Week In Review  |  Company News  |  Deals

GenoSplice technology S.a.r.l., Institut Curie deal

Curie-Cancer, which is responsible for developing Institut Curie's partnerships, and GenoSplice partnered to develop bioinformatics solutions for cancer genomics. GenoSplice will gain access to Curie-Cancer's genomic platform for...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >